Should Medical Marijuana be Federally Legalized?

Should Medical Marijuana be Federally Legalized?

Millions of Americans take prescription drugs to treat a plethora of illnesses and symptoms, but not all drugs are created equal. The question of whether or not to consider marijuana a viable medical treatment remains a hot button issue. In states like California, medical marijuana clubs have flourished despite their federal illegality. Should the federal government allow states to make their own decisions, or is marijuana nothing more than a dangerous narcotic?

Next question in Drug Law

  • “No”
  • “Objection”
Dr Voth

Medical Marijuana Bypasses the FDA and Jeopardizes Consumer Protection

Dr. Eric Voth

M.D., FACP

The FDA opposes medical excuse marijuana.  Modern medicine does not condone smoking medications or potions. We follow a process through the FDA to assure that medications are safe and effective. Marijuana has never passed the safety and efficacy tests by the FDA and thus jeopardizes consumer protection. Medicine by popular vote is a dangerous precedent. Some treatments are thought to be useful but turn out to be ineffective or dangerous when submitted to rigorous scientific study.

Evidence

IcotextText
Medicinal Applications of Delta-9-tetrahydrocannabinol and Marijuana
Voth EA, Schwartz RH. Medicinal applications of Delta-9-tetrahydrocannabinol and marijuana. Annals of Internal Medicine 1997;126:791-798
IcotextText
Guidelines for Prescribing Medical Marijuana
Voth EA. "Guidelines for prescribing medical marijuana." Western Journal of Medicine 2001;175:305-306
IcotextText
The Medical Excuse Marijuana Controversy
Voth EA, A peek into Pandora’s box: the medical excuse marijuana controversy. J Addict Diseases 2003;22:27-46
IcotextText
Marijuana and Cannabinoid Research:Current Status and Future Potential
Voth, EA. Marijuana and cannabinoid research:Current status and future potential Journal of Global Drug Policy and Practice 2007; 1 issue 1
IcotextText
Alliance for Cannabis Therapeutics v. DEA Court Ruling
United States Court of Appeals for the District of Columbia. Feb. 1994, 92-1168 Petition for the review of controlled substance. Alliance for Cannabis Therapeutics v. Drug Enforcement Administration. [1) The drug’s chemistry must be known and reproducible. 2) There must be adequate safety studies. 3) There must be adequate and well-controlled studies proving efficacy. 4) The drug must be accepted by qualified experts. 5) The scientific evidence must be widely available. , "The administrator reasonably accorded more weight to the opinions of the experts than to the laymen and doctors on which the petitioners relied."]
Post a Comment

Next Argument Previous Next

"No" Dr Voth
"No" Drug Free America
"Yes" NORML
"Yes" Marijuana Policy Project
"Yes" ASA
Most Objections

Marijuana by Prescription?

Loading
  • Yes
  • No
Vote
View Results

Ask Your Friends to Vote

Spotlight

Loading
  • Dr Voth
    Dr. Eric Voth is the chairman of the Institute on Global Drug Policy and the editor of the Journal on Global Drug Policy and Practice More

Subscribe to Opposing News

Biweekly updates on new debates and experts

Loading
Thank you for signing up

Please check your email to confirm your subscription.